Pharmacenter Hungary has developed two oncology drugs in a HUF 535 million project, supported by a HUF 298m grant from the National Research, Development and Innovation Fund, the company said in a statement. The project started in October 2021 and was completed in September 2025. One of the resulting products is used in the therapy […]